A carregar...
Targeting dendritic cells in situ for breast cancer immunotherapy
We have recently developed a protein vaccine against breast cancer in which HER2 is delivered to dendritic cells (DCs) in vivo through receptors expressed on their surface. Our results indicate that this is a promising approach to induce durable, broad and integrated immunity against breast cancer.
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3518515/ https://ncbi.nlm.nih.gov/pubmed/23243606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20982 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|